Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines

Código QR

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines

Coronavirus disease 2019 (COVID-19) pandemic is a serious threat to global public health and social and economic development. Various vaccine platforms have been developed rapidly and unprecedentedly, and at least 16 vaccines receive emergency use authorization (EUA). However, the causative pathogen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yandi Zhang, Jo-Lewis Banga Ndzouboukou, Mengze Gan, Xiaosong Lin, Xionglin Fan
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	COVID-19 SARS-CoV-2 variants vaccine efficacy immune evasive epidemiology Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/b58f191aff914f5eb4c8f384750a530c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy
por: Daniela Loconsole, et al.
Publicado: (2021)

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
por: Kadhim Hayawi, et al.
Publicado: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Fuxing Lou, et al.
Publicado: (2021)

High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2
por: Rita Jaafar, et al.
Publicado: (2021)

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
por: Dandan Tian, et al.
Publicado: (2021)

Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
por: Wei-Shuo Lin, et al.
Publicado: (2021)

Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
por: Mohammad R. Hasan, et al.
Publicado: (2021)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Felipe Melo-González, et al.
Publicado: (2021)

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
por: Daniel J. Sheward, et al.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021)

Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2
por: Matteo Calcagnile, et al.
Publicado: (2021)

A review of epidemiology, clinical features and disease course, transmission dynamics, and neutralization efficacy of SARS-CoV-2 variants
por: Paroma Deb, et al.
Publicado: (2021)

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study
por: Shepherd R. Singer, M.D., et al.
Publicado: (2021)

Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations
por: Jobin John Jacob, et al.
Publicado: (2021)

Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines
por: William M. de Souza, et al.
Publicado: (2021)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
por: Lin Yang, et al.
Publicado: (2021)

A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue
por: Rama Devudu Puligedda, et al.
Publicado: (2021)

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
por: Lixin Lin, et al.
Publicado: (2021)

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro
por: Hsiang-Chi Huang, et al.
Publicado: (2021)

Impact of the Double Mutants on Spike Protein of SARS-CoV-2 B.1.617 Lineage on the Human ACE2 Receptor Binding: A Structural Insight
por: Mohd Imran Khan, et al.
Publicado: (2021)

SARS-CoV-2 immunity and an overview of the COVID-19 vaccines
por: Marković Miloš
Publicado: (2021)

An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
por: Mohammad Enamul Hoque Kayesh, et al.
Publicado: (2021)

Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
por: Soheil Ghasemi, et al.
Publicado: (2021)

Structural-Dynamics and Binding Analysis of RBD from SARS-CoV-2 Variants of Concern (VOCs) and GRP78 Receptor Revealed Basis for Higher Infectivity
por: Abbas Khan, et al.
Publicado: (2021)

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
por: Doris Urlaub, et al.
Publicado: (2021)

Effectiveness of Telephone Monitoring in Primary Care to Detect Pneumonia and Associated Risk Factors in Patients with SARS-CoV-2
por: Jose Miguel Baena-Díez, et al.
Publicado: (2021)

First Report of Two Cases of Löfgren’s Syndrome after SARS-CoV-2 Vaccination-Coincidence or Causality?
por: Jan-Gerd Rademacher, et al.
Publicado: (2021)

High-Throughput Wastewater SARS-CoV-2 Detection Enables Forecasting of Community Infection Dynamics in San Diego County
por: Smruthi Karthikeyan, et al.
Publicado: (2021)

Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens
por: Kevin S. Kuchinski, et al.
Publicado: (2022)

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
por: Fatiha M. Benslimane, et al.
Publicado: (2021)

XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
por: Bernard Vanhove, et al.
Publicado: (2021)

Review of the early reports of the epidemiological characteristics of the B.1.1.7 variant of SARS-CoV-2 and its spread worldwide
por: Yeonju Kim, et al.
Publicado: (2021)

A Genome Epidemiological Study of SARS-CoV-2 Introduction into Japan
por: Tsuyoshi Sekizuka, et al.
Publicado: (2020)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
por: Yuko Sakai-Tagawa, et al.
Publicado: (2021)

Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
por: Asish Kumar Ghosh, et al.
Publicado: (2021)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Antonio J. Martín-Galiano, et al.
Publicado: (2021)

MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis
por: Vineet D. Menachery, et al.
Publicado: (2017)

The vaccination threshold for SARS-CoV-2 depends on the indoor setting and room ventilation
por: A. Mikszewski, et al.
Publicado: (2021)